Suzuki K, Bruce W R
J Natl Cancer Inst. 1986 Jun;76(6):1129-32.
Intrarectal exposure of the colon epithelium of the C57BL/6J female mouse to deoxycholic acid [(DCA) CAS: 83-44-3] markedly increased its sensitivity to orally administered 1,2-dimethylhydrazine [(DMH) CAS: 540-73-8]. While 4 mg DMH/kg body weight by itself increased the level of nuclear damage from a background level of 0.2-0.45 aberration per crypt, DMH when combined with DCA at a dose of 150 mg/kg increased the aberrations from 0.2 to 1.75 per crypt. This effect was observed over a wide range of DCA doses (20-300 mg/kg) and was evident when DMH was given up to 10 hours after the DCA. Similar results were observed with DCA in conjunction with benzo[a]pyrene (CAS: 50-32-8) and 2-amino-3,4-dimethylimidazo(4,5-f)quinoline (CAS: 77094-11-2), though in these cases the time at which the peak of nuclear aberrations occurred was somewhat later. No enhancement was seen with DCA and gamma-radiation. These results show that DCA can enhance the nucleotoxic effects of several carcinogens and suggest that DCA can act as a cocarcinogen. The enhancement may be due to the effect of the bile acid on proliferation of the colon epithelial cells or to its effect on the permeability of mucosal cells.
将C57BL/6J雌性小鼠的结肠上皮直肠内暴露于脱氧胆酸[(DCA),化学物质登记号:83-44-3],可显著增加其对口服1,2-二甲基肼[(DMH),化学物质登记号:540-73-8]的敏感性。虽然单独给予4mg DMH/kg体重会使每个隐窝的核损伤水平从背景水平的0.2 - 0.45个畸变增加,但当DMH与150mg/kg的DCA联合使用时,每个隐窝的畸变从0.2增加到了1.75。在很宽的DCA剂量范围(20 - 300mg/kg)内都观察到了这种效应,并且当在给予DCA后长达10小时给予DMH时这种效应依然明显。DCA与苯并[a]芘(化学物质登记号:50-32-8)和2-氨基-3,4-二甲基咪唑并[4,5-f]喹啉(化学物质登记号:77094-11-2)联合使用时也观察到了类似结果,不过在这些情况下核畸变峰值出现的时间稍晚一些。DCA与γ辐射联合使用时未观察到增强作用。这些结果表明,DCA可增强几种致癌物的核毒性作用,并提示DCA可作为一种促癌剂。这种增强作用可能是由于胆汁酸对结肠上皮细胞增殖的影响,或者是其对黏膜细胞通透性的影响。